Log in to save to my catalogue

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticle...

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticle...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2351037596

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

About this item

Full title

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2019-01, Vol.26 (1), p.700-707

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Efficient delivery of brain-targeted drugs is highly important for successful therapy in Parkinson's disease (PD). This study was designed to formulate borneol and lactoferrin co-modified nanoparticles (Lf-BNPs) encapsulated dopamine as a novel drug delivery system to achieve maximum therapeutic efficacy and reduce side effects for PD. Dopamine Lf-...

Alternative Titles

Full title

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2351037596

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2351037596

Other Identifiers

ISSN

1071-7544,1521-0464

E-ISSN

1521-0464

DOI

10.1080/10717544.2019.1636420

How to access this item